Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 20, 2026
AXT, Inc. (AXTI): Reclaiming $100 Could Deliver a +35% Return

AXT, Inc. (AXTI): Reclaiming $100 Could Deliver a +35% Return

Key Takeaways

  • AXT, Inc. (AXTI) closed near $73, making a return to the $100 level a gain of roughly 35% from current prices.
  • The strongest bull case rests on record demand for indium phosphide (InP) substrates used in AI data center optical transceivers.
  • Wall Street's average 12-month analyst price target of about $91.60 sits just below $100, while the highest published target reaches $125.
  • Key risks include China export-permit delays, heavy insider selling, elevated short interest, and extreme share-price volatility.
  • The stock previously traded above $100 and peaked near $143 earlier in 2026, so $100 is a realistic but execution-dependent milestone rather than a new frontier.

Why the $100 Level Matters

After one of the most dramatic re-ratings in the semiconductor sector, AXT, Inc. — a Fremont, California-based maker of compound semiconductor substrates — has become a focal point for investors asking whether it can reclaim the psychologically important $100 mark. The stock traded below $2 a year ago before surging to an all-time high near $143 in May 2026, driven almost entirely by its exposure to artificial intelligence infrastructure. A sharp pullback has since brought shares back to the low-to-mid $70s, reviving the question of whether a return to $100 is achievable.

Understanding AXT's Business

AXT develops and manufactures high-performance compound and single-element semiconductor substrates, including indium phosphide (InP), gallium arsenide (GaAs), and germanium (Ge). These wafers are used where traditional silicon cannot meet the performance requirements of advanced optical and electronic devices. The company's manufacturing is concentrated in its majority-owned Chinese subsidiary, Beijing Tongmei Xtal Technology, which is pursuing a listing on Shanghai's STAR Market.

The investment narrative changed in 2026 as AXT positioned itself as a critical supplier of InP substrates for the lasers and photodetectors inside high-speed optical transceivers used in AI data centers. Management has reported a record InP backlog exceeding $100 million and plans to roughly double InP capacity in both 2026 and 2027. I also checked this using Tickeron’s AI Trend Prediction Engine to see how the stock compares to others in the industry.

Where the Stock Stands Today

AXT closed at approximately $73.43 in its most recent session, with a 52-week range spanning roughly $2.20 to $143.16. The stock carries a market capitalization of roughly $4.8 billion and a beta well above the broader market, reflecting its exceptional volatility. Fundamentals have improved sharply: the company's latest quarterly report showed earnings per share of $0.19 versus an expected $0.07, revenue of about $47.6 million against a $34 million consensus estimate, and third-quarter guidance for EPS of $0.30 to $0.32 — a meaningful step toward sustained profitability after years of losses.

Drivers That Could Push Shares Higher

Reaching $100 would likely require continued momentum in the AI optical networking cycle that has fueled AXT's ascent. If the InP backlog converts into shipped revenue on schedule and export permits from China's Ministry of Commerce normalize, the capacity expansion could support materially higher sales. A successful Beijing Tongmei STAR Market listing would add a separate catalyst by unlocking independent capital and potentially validating the value of AXT's China-based manufacturing operations. Several analysts have already raised targets toward the $90 to $125 range, signaling that the Street views the demand cycle as durable rather than transient.

Obstacles That Could Slow Progress

The obstacles are substantial. Because AXT manufactures in China and sells substrates to overseas customers, export-permit timing directly controls how quickly backlog becomes revenue — a recurring source of uncertainty. Revenue remains heavily concentrated in Asia Pacific, which accounted for the vast majority of recent sales, while North America represented only a small fraction. The company's April 2026 equity raise of roughly $632.5 million funded expansion but also diluted existing shareholders. Insiders sold more than 250,000 shares worth roughly $27.8 million over the latest quarter, and short interest has remained elevated at a significant share of the public float. Any setback tied to Tongmei, permits, or a cooling in AI infrastructure spending could reignite downside volatility.

Analyst Views and Price Targets

The consensus analyst price target for AXTI stands near $91.60, just shy of the $100 mark, with a high estimate of $125 and a low estimate around $55. The average rating is a "Buy." This positioning is telling: the analyst community broadly agrees the stock can move higher from current levels, but the central tendency stops short of $100. Reaching that level would require either an upward revision of consensus targets or a valuation premium beyond what analysts currently model.

Technical Levels Worth Watching

From a technical analysis perspective, the $65 to $80 zone has acted as a post-offering consolidation range, making it a key support level to watch. A sustained hold above this area would support the case for a retest of higher levels, while a decisive break below roughly $60 would call the rebound thesis into question. On the upside, $100 is both a psychological round number and a former trading area the stock moved through during its 2026 surge, which could create supply — that is, resistance — from investors looking to sell as prices recover toward prior levels. From what I see, the patterns here align with broader sector moves tracked by Tickeron’s AI Real Time Patterns.

Final Assessment

A return to $100 for AXTI is plausible but far from guaranteed. The stock has already demonstrated it can trade above that level, and its AI-driven demand story, record backlog, and improving profitability provide genuine support. However, the path depends heavily on export-permit approvals, successful capacity execution, and the Tongmei listing — each of which carries meaningful uncertainty. With the consensus analyst target sitting just below $100 and short interest and insider selling still elevated, investors should monitor quarterly revenue conversion, permit timelines, and the company's ability to sustain margins as capacity ramps. The $100 milestone is within reach, but only if execution matches the ambitious growth already priced into the stock's remarkable run.

AI Daily Buy/Sell Signals

One tool I rely on for fast-moving names like this is Tickeron’s AI Daily Buy/Sell Signals. It generates daily AI-driven Buy, Sell, or Hold signals across thousands of stocks by analyzing technical behavior and market conditions. For volatile stocks that have already seen triple-digit swings in a year, these signals offer a useful complement to fundamental work when monitoring entry points or position adjustments.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AXTI

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


AXTI in upward trend: price rose above 50-day moving average on August 06, 2026

AXTI moved above its 50-day moving average on August 06, 2026 date and that indicates a change from a downward trend to an upward trend. In of 48 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 30, 2026. You may want to consider a long position or call options on AXTI as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AXTI just turned positive on July 21, 2026. Looking at past instances where AXTI's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for AXTI crossed bullishly above the 50-day moving average on August 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where AXTI advanced for three days, in of 277 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for AXTI moved out of overbought territory on August 18, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 67 cases where AXTI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXTI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AXTI broke above its upper Bollinger Band on August 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for AXTI entered a downward trend on August 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AXTI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 65, placing this stock slightly worse than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.456) is normal, around the industry mean (8.092). AXTI's P/E Ratio (2450.333) is considerably higher than the industry average of (164.260). AXTI's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.482). AXTI has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.006). P/S Ratio (30.395) is also within normal values, averaging (33.477).

Notable companies

The most notable companies in this group are Applied Materials (NASDAQ:AMAT), Lam Research Corp (NASDAQ:LRCX), KLA Corporation (NASDAQ:KLAC), Teradyne (NASDAQ:TER), Ambarella (NASDAQ:AMBA).

Industry description

The electronic production equipment industry makes equipment used to produce semiconductors. Such equipment includes wafer fabrication, plasma etching and photo-resist processing equipment. The industry also makes chemical vapor deposition processing systems and photomasks, which are high-purity quartz plates that contain patterns to define integrated circuits layouts. Applied Materials, Inc., Lam Research Corporation, and KLA-Tencor Corporation are examples of electronic production equipment manufacturing companies.

Market Cap

The average market capitalization across the Electronic Production Equipment Industry is 63.91B. The market cap for tickers in the group ranges from 555.66K to 685.91B. ASML holds the highest valuation in this group at 685.91B. The lowest valued company is AVSR at 555.66K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Production Equipment Industry was -10%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was 28%. TRT experienced the highest price growth at -1%, while SMTK experienced the biggest fall at -33%.

Volume

The average weekly volume growth across all stocks in the Electronic Production Equipment Industry was 26%. For the same stocks of the Industry, the average monthly volume growth was 48% and the average quarterly volume growth was -28%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 34
Price Growth Rating: 42
SMR Rating: 73
Profit Risk Rating: 64
Seasonality Score: -23 (-100 ... +100)
View a ticker or compare two or three
AXTI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufactures of high-performance compound semiconductor substrates

Industry ElectronicProductionEquipment

Profile
Details
Industry
Electronic Production Equipment
Address
4281 Technology Drive
Phone
+1 510 438-4700
Employees
1075
Web
http://www.axt.com
Interact to see
Advertisement
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
CME Group delivered record 2025 revenue of $6.52 billion, up 6% year-over-year. Q4 adjusted EPS of $2.77 exceeded expectations.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
KKR reported Q4 2025 adjusted EPS of $1.12, slightly below the $1.14 consensus estimate. The firm raised a record $129 billion in 2025, surpassing 80% of its $300 billion fundraising goal for 2024–2026.
Intercontinental Exchange (ICE) has navigated recent market volatility while remaining within its 52-week range. Broader weakness in financial data and exchange operators has created short-term pressure, but ICE’s diversified business model continues to provide stability.
Barrick delivered record Q4 and full-year 2025 results, reporting $6 billion in Q4 revenue and full-year EPS of $2.93, ahead of expectations.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
AXT, Inc. (AXTI): Reclaiming $100 Could Deliver a +35% Return